TickerFactsScreenerDevelopers

Regencell Bioscience Holdings Ltd (RGC) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2018: -$1.45M2019: -$1.84M2020: -$2.65M2021: -$4.00M2022: $17.07M2023: $12.03M2024: $8.22M2025: $4.86M$4.86M
2018Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$4.86M-40.9%
2024$8.22M-31.7%
2023$12.03M-29.5%
2022$17.07M+526.9%
2021-$4.00M-50.8%
2020-$2.65M-44.2%
2019-$1.84M-27.0%
2018-$1.45M—